Home
  • Donate money to KEI
  • Listserves
  • Main Areas of Work
  • Events
  • Publications
  • Blogs
  • About KEI

Knowledge Ecology International

Attending and mending the knowledge ecosystem

Navigation

  • Site Map
  • Recent posts
  • Feed aggregator
  • Polls
  • Groups

Round II of the Paris Accord took place in Paris on October 23 and 24, 2009.

Book navigation

  • Right to Read for Persons with Reading Disabilities
  • About KEI
  • Access to Medical Technologies
  • Berne Convention Appendix Regarding Special Provisions Regarding Developing Countries
  • Competition Policy
  • Data points on prices of medical technologies
  • Databases
  • Enforcement and Remedies to Infringement
  • Events
  • General Access to Knowledge Issues
  • Government Funded Inventions
  • Knowledge Governance Fora
  • Main Areas of Work
  • Medical diseases, conditions and technologies
  • Nuclear Proliferation
  • Patent Policy
  • Prizes to stimulate innovation
  • Publications and Research Notes
  • Test Data
  • Timelines
  • Transparency

User login

What is OpenID?
  • Log in using OpenID
  • Cancel OpenID login
  • Create new account
  • Request new password
Home

tenofovir

KEI asks FTC to Investigate Gilead Effort To Control Market For AIDS Drugs Ingredients

  • gilead
  • tenofovir
  • Competition Policy

Press Release

15 Feb 07

FMI  James Love +1.202.332.2670, cell +1.202.361.3040, james.love@keionline.org   (See attachment for patent and health experts contact information)

FTC ASKED TO INVESTIGATE GILEAD EFFORT TO CONTROL MARKET FOR AIDS DRUGS INGREDIENTS

[Complaint available here:
http://www.keionline.org/misc-docs/ftcgilead12feb07.pdf ]

  • Read more
Syndicate content

Support KEI

WASHINGTON 1621 Connecticut Ave. NW, Suite 500, Washington, DC 20009 /TEL: +1.202.332.2670 · FAX +1.202.332.2673 GENEVE 1 Route des Morillons, CP 2100, 1211 Genève 2, Switzerland TEL: +41.22.791.6727
THEME DESIGN Copyright © 2009 under GPL by Tribute Media. Site Powered by Drupal.